-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
-
Summary
-
Eton Pharmaceuticals, Inc. quarterly Earnings Per Share, Diluted history and growth rate from Q1 2020 to Q3 2024.
- Eton Pharmaceuticals, Inc. Earnings Per Share, Diluted for the quarter ending September 30, 2024 was 0.02 USD/shares.
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Growth (%)